Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2026-01-01 @ 7:39 AM
Study NCT ID:
NCT00036569
Status:
COMPLETED
Last Update Posted:
2012-02-13
First Post:
2002-05-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-05
Start Date Type:
None
Primary Completion Date:
2010-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-01
Completion Date Type:
ACTUAL
First Submit Date:
2002-05-10
First Submit QC Date:
None
Study First Post Date:
2002-05-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-09-20
Results First Submit QC Date:
None
Results First Post Date:
2012-02-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-01-10
Last Update Post Date:
2012-02-13
Last Update Post Date Type:
ESTIMATED